Module 1 Flashcards
(81 cards)
What is pharmacology
The study of drugs
What are some of the various aspects that can be included in the study of drugs?
1) How a drug is delivered (it’s route of administration).
2) How a drug works (it’s mechanism of action).
3) The therapeutic effect of drugs on patients.
4) The adverse effects of drugs on patients.
What are the classifications of therapeutics?
1) Drugs – Traditional drugs (i.e., chemical agents).
2) Biologics – antibodies, hormones.
3) Natural Health Products – herbals, vitamins, minerals.
What are the three directorates used to oversee therapeutics in Canada?
- Therapeutic products directorate
- Biologics and Generic Therapies directorate
- Natural Health Products directorate
Summarize Canadian Drug Legislation (photo)
Food and Drugs Act and Regulations –> Health Canada –> Health Canada Products and Food Branch –> Various Directorates
How must we think of drugs?
As chemicals
Within every pill, tablet, or capsule is what?
The many molecules of a chemical; it is the chemical that actually produces the pharmacological effect.
What are the three types of names used for naming drugs?
- Chemical Name
- Generic Name
- Trade Name
Describe chemical name
Describes the chemical structure of the molecule. Is used by chemists but not by many others. Not commonly used in pharmacology.
Describe generic name
A unique name that identifies a drug. The generic name is the name most often used in Pharmacology.
Which type of name is used by health care professionals?
Generic (not always the case but should be)
Describe trade name
The name assigned by a drug company. It is usually easy to remember and marketable. The major problem with trade names is many companies may make the same drug, therefore it may have many different trade names.
How can drug routes of administration be broadly classified?
Enteral, Parenteral, Other (such as topical)
Describe the preclinical testing phase (of approval of marketed drugs in Canada)
-In cultured cells, living tissues, or experimental animals
-evaluate biological effects, pharmacokinetics, and toxicity
-lasts approx 6.5 yrs
Describe the clinical trial application (approval of marketed drugs in Canada)
must be submitted to Health Canada prior to any human studies
Describe the phase I clinical trial phase (of approval of marketed drugs in Canada)
-20-100 healthy volunteers
-evaluation of pharmacokinetics and pharmacodynamics
Describe the phase II clinical trial phase (of approval of marketed drugs in Canada)
-300-500 patients with the targeted disorder
-therapeutic effectiveness, side effects, and dosing information is gathered
Describe the phase III clinical trial phase (of approval of marketed drugs in Canada)
-500-5000 patients with the target disorder
-therapeutic effectiveness verified, long term side effects assessed
Describe the phase IV clinical trial phase (of approval of marketed drugs in Canada)
-Post marketing surveillance. Health Canada monitors the efficacy and safety of the drug after it has been marketed (after new drug submission (NDS) submitted to Health Canada
Describe new drug submission (NDS) submitted to Health Canada
After phase III clinical trial.
A report that details therapeutic effectiveness and safety. Includes results from pre-clinical and clinical studies. If approved, Health Canada issues a Notice of Compliance (NOC) and a Drug Information Number (DIN). Both are required to market the drug.
List the 7 steps for approval of marketed drugs in Canada
- Preclinical testing
- Clinical trial application
- Phase I clinical trial
- Phase II clinical trial
- Phase III clinical trial
- New drug submission (NDS) submitted to health Canada
- Phase IV clinical trial
What do enteral routes of administration involve?
Oral or Rectal
What do parenteral routes of administration involve?
Intravenous, Intramuscular, Subcutaneous
What do topical routes of administration involve?
Creams or Patches